Catalyst
Description
  • Value proposition

    Our Vision : We have High Standards - We Build Companies - We have Impact

    Kurma Partners is a key European venture capital group specialized in healthcare, with €470 million under management, with two dedicated franchises : Kurma Biofund focused on therapeutic (current active fund KBIII) and Kurma Diagnostics focused on diagnostic and digital health (current active fund Kurma Dx2).

    Biotechnology, Lifesciences, Drug Development, Technology transfer, Rare diseases, Digital Healh, Diagnostics, and Medtech

  • Original language

    Our Vision : We have High Standards - We Build Companies - We have Impact

    Kurma Partners is a key European venture capital group specialized in healthcare, with €470 million under management, with two dedicated franchises : Kurma Biofund focused on therapeutic (current active fund KBIII) and Kurma Diagnostics focused on diagnostic and digital health (current active fund Kurma Dx2).

  • Kurma Partners - Major player in the funding of healthcare and biotechnology in Europe

    Kurma Partners - Major player in the funding of healthcare and biotechnology in Europe

  • https://www.kurmapartners.com/en
Entity interactions
Entity TypeTweets Articles
BNP Paribas Fortis BNP Paribas Fortis
Banking
Other

28 Feb 2022


Volotea Volotea
spacetech, Airlines and Aviation
Other

3 May 2018


Kwit Kwit
Wellness and Fitness Services, healthtech
Other

30 Jun 2022


IPEM IPEM
Venture Capital and Private Equity Principals
Other

25 Sep 2022


European Investment Bank (EIB) European Investment Bank (EIB)
Banking
Other

23 Nov 2021


TreeFrog Therapeutics TreeFrog Therapeutics
Biotechnology Research, biotech, deeptech
Other

13 Oct 2022


Leavy.co Leavy.co
Software Development, traveltech
Other

28 Feb 2022


Highland Europe Highland Europe
Venture Capital and Private Equity Principals
Other

3 May 2018


Casdin Capital, LLC Casdin Capital, LLC
Financial Services
Other

23 Nov 2021


Innogest Capital Innogest Capital
Venture Capital and Private Equity Principals
Other

22 Mar 2021


Radars
Loading...